Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
03/01/2023* 08:00 EST Earnings Call Q4 2022 -- -- --
03/01/2023* -- Results Q4 2022 -- 0.00 --
10/27/2022 08:00 EST Earnings Call Q3 2022 -- -- --
10/27/2022 -- Results Q3 2022 0.00 -0.06 105.6%
08/03/2022 08:00 EST Earnings Call Q2 2022 -- -- --
08/03/2022 -- Results Q2 2022 -0.11 -0.06 -72.98%
05/04/2022 08:00 EST Earnings Call Q1 2022 -- -- --
05/04/2022 -- Results Q1 2022 -0.08 -0.01 -1.50K%
*Estimated Date/Time

Earnings

Next Report Date 03/01/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 10/27/2022
Beat/Miss Upgrade
Return Since 7.02%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.
URL https://www.amarincorp.com
Investor Relations URL https://investor.amarincorp.com/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 01, 2023 (est.)
Last Earnings Release Oct. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
92.92%
62.96%
30.19%
239.4%
57.53%
-77.19%
-31.08%
-63.80%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-13.26%
-28.72%
-14.91%
-21.08%
-68.54%
192.6%
-11.52%
20.96%
14.85%
-32.01%
-41.16%
-26.30%
-55.10%
-54.87%
268.7%
-62.47%
-9.79%
--
-66.42%
64.94%
-13.92%
-79.13%
349.2%
-30.43%
-45.07%
--
--
-9.75%
-69.24%
8.88%
25.15%
-74.54%
-75.68%
As of December 02, 2022.

Profile

Edit
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.
URL https://www.amarincorp.com
Investor Relations URL https://investor.amarincorp.com/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 01, 2023 (est.)
Last Earnings Release Oct. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter AMRN Tweets